Exploring the screening capacity of the Fear of Cancer Recurrence Inventory‐Short Form for clinical levels of fear of cancer recurrence
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Objective: Fear of cancer recurrence (FCR) is a common concern among cancer survivors. Identifying survivors with clinically significant FCR requires validated screening measures and clinical cut‐offs. We evaluated the Fear of Cancer Recurrence Inventory‐Short Form (FCRI‐SF) clinical cut‐off in 2 samples. Methods: Level of FCR in study 1 participants (from an Australian randomized controlled trial: ConquerFear) was compared with FCRI‐SF scores. Based on a biopsychosocial interview, clinicians rated participants as having nonclinical, subclinical, or clinical FCR. Study 2 participants (from a Canadian FCRI‐English validation study) were classified as having clinical or nonclinical FCR by using the semistructured clinical interview for FCR (SIFCR). Receiver operating characteristic analyses evaluated the screening ability of the FCRI‐SF against clinician ratings (study 1) and the SIFCR (study 2). Results: In study 1, 167 cancer survivors (mean age: 53 years, SD = 10.1) participated. Clinicians rated 43% as having clinical FCR. In study 2, 40 cancer survivors (mean age: 68 years, SD = 7.0) participated; 25% met criteria for clinical FCR according to the SIFCR. For both studies 1 and 2, receiver operating characteristic analyses suggested a cut‐off ≥22 on the FCRI‐SF identified cancer survivors with clinical levels of FCR with adequate sensitivity and specificity. Conclusions: Establishing clinical cut‐offs on FCR screening measures is crucial to tailoring individual care and conducting rigorous research. Our results suggest using a higher cut‐off on the FCRI‐SF than previously reported to identify clinically significant FCR. Continued evaluation and validation of the FCRI‐SF cut‐off is required across diverse cancer populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cicchetti, D. V. (1994) · Psychological Assessment · doi:10.1037/1040-3590.6.4.284 · Cited by 9,349
Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models
Zou, K. H., O’Malley, A. J., & Mauri, L. (2007) · Circulation · doi:10.1161/circulationaha.105.594929 · Cited by 1,473
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217 · cited 5×
“Clinical FCR presentation may be somewhat heterogeneous across individuals due to variability in coping strategies employed.(2,13,25) However, it is important to identify individuals with clinical FCR, as they may neglect appropriate screening behaviors in favor of actions that temporarily reduce fear, in an attempt t…”
BackgroundResultSelf-citationSimard, S., & Savard, J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0444-y · Cited by 608 · cited 5×
“80).(7) It is highly correlated with FCRI total score (r = 0.”
BackgroundMethodInfluentialSelf-citationLebel, S., Ozakinci, G., Humphris, G., Mutsaers, B., Thewes, B., Prins, J., Dinkel, A., Butow, P., & on behalf of the University of Ottawa Fear of Cancer Recurrence Colloquium attendees (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3272-5 · Cited by 586
Self-citationKoch, L., Jansen, L., Brenner, H., & Arndt, V. (2013) · Psycho-Oncology · doi:10.1002/pon.3022 · Cited by 511
Screening and comorbidity of clinical levels of fear of cancer recurrence
Simard, S., & Savard, J. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0424-4 · Cited by 329 · cited 8×
“In study 2, the SIFCR interviews were conducted via phone by senior psychology graduate students supervised by SL and SS.(9) The studies presented here, and other research,(21,22) highlight the challenge of reliably identifying cancer survivors experiencing clinical FCR using brief measures when no accepted gold‐stand…”
BackgroundMethodResultInfluentialSelf-citationFear of cancer recurrence: a systematic literature review of self‐report measures
Thewes, B., Butow, P., Zachariae, R., Christensen, S., Simard, S., & Gotay, C. (2012) · Psycho-Oncology · doi:10.1002/pon.2070 · Cited by 262
Self-citationFear of cancer recurrence: a theoretical review and novel cognitive processing formulation
Fardell, J. E., Thewes, B., Turner, J., Gilchrist, J., Sharpe, L., Smith, A. ‘., Girgis, A., & Butow, P. (2016) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0512-5 · Cited by 247 · cited 2×
“Many researchers, including the authors, view FCR as existing along a continuum, where at some critical point, high FCR levels become distressing and adversely impact on day‐to‐day functioning and psychological wellbeing.(2,19,20) The analyses presented here attempt to provide a data‐led position on identifying patien…”
BackgroundSelf-citationFear of cancer recurrence: specific profiles and nature of intrusive thoughts
Simard, S., Savard, J., & Ivers, H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0136-8 · Cited by 229 · cited 1×
“At clinical levels of FCR, thoughts about recurrence are unbidden and often reported as intrusive and difficult to dismiss.(24) How intrusive thoughts translate into functional impairment is unclear.”
BackgroundSelf-citationthe FCR Study Advisory Committee, Thewes, B., Butow, P., Bell, M. L., Beith, J., Stuart-Harris, R., Grossi, M., Capp, A., & Dalley, D. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-011-1371-x · Cited by 213 · cited 1×
“Survivors with high FCR may engage in excessive self‐checking but avoid formal screening;(26-28) more readily seek readmission to specialized cancer centres;(29) and use more complementary and alternative medicines.(26,30) Recent work toward defining what constitutes normal versus clinical FCR levels signifies an impo…”
BackgroundSelf-citationmembers of the Conquer Fear Authorship Group, Butow, P. N., Bell, M. L., Smith, A. B., Fardell, J. E., Thewes, B., Turner, J., Gilchrist, J., Beith, J., Girgis, A., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-201 · Cited by 117 · cited 1×
“Cancer survivors from hospitals around Australia were invited to participate in the RCT through invitation mail‐outs, clinician approaches, and advertising through cancer research interest groups.(14) Interested survivors completed the FCRI‐SF; those scoring ≥13 and meeting all other eligibility criteria were given a…”
MethodSelf-citationMutsaers, B., Jones, G., Rutkowski, N., Tomei, C., Séguin Leclair, C., Petricone-Westwood, D., Simard, S., & Lebel, S. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3248-5 · Cited by 109 · cited 3×
“Differences between participants and nonparticipants are reported elsewhere.(16) The Ottawa Hospital ethics board approved this study, and all participants gave informed consent.”
BackgroundSelf-citationEmpirical validation of the English version of the Fear of Cancer Recurrence Inventory
Lebel, S., Simard, S., Harris, C., Feldstain, A., Beattie, S., McCallum, M., Lefebvre, M., Savard, J., & Devins, G. M. (2016) · Quality of Life Research · doi:10.1007/s11136-015-1088-2 · Cited by 90
Self-citationDirkse, D., Hadjistavropoulos, H. D., Alberts, N. A., Karin, E., Schneider, L. H., Titov, N., & Dear, B. F. (2020) · Journal of Cancer Survivorship · doi:10.1007/s11764-019-00810-9 · Cited by 29
Research works printed but not linked: 16
- 10.1002/pon.1346 · DOI · Paper page
- 10.1007/s00520-007-0296-x · DOI
- Simard S, 2009, Screening and comorbidity of clinical fear of cancer recurrence, Psycho‐Oncol, 18, 171
- 10.1002/pon.3430 · DOI · Paper page
- 10.1007/s11764-014-0383-1 · DOI
- Herman S, 2013, Screening Dysfunctional Fear of Cancer Recurrence in Breast Cancer Patients Wishing for Psychological Help: The Validity of the Fear of Cancer Recurrence Inventory (FCRI)
- 10.1007/s00520-015-2943-y · DOI
- 10.1002/(SICI)1099-1611(199706)6:2<95::AID-PON250>3.0.CO;2-B · doi:10.1002/(sici)1099-1611(199706)6:2<95::aid-pon250>3.0.co;2-b
- 10.1097/NCC.0b013e3182813a17 · DOI · Paper page
- 10.1007/s10549-016-3730-2 · DOI
- 10.1002/pon.4103 · DOI
- 10.1002/pon.1481 · DOI · Paper page
- 10.1037/a0030186 · DOI
- 10.1007/s10865-013-9537-2 · DOI
- 10.1016/S0936-6555(97)80055-6 · DOI · Paper page
- 10.1111/j.1365-2354.2006.00722.x · DOI · Paper page
Cited by
Luigjes‐Huizer, Y. L., Tauber, N. M., Humphris, G., Kasparian, N. A., Lam, W. W. T., Lebel, S., Simard, S., Smith, A. B., Zachariae, R., Afiyanti, Y., et al. (2022) · Psycho-Oncology · doi:10.1002/pon.5921 · Cited by 332
Self-citationSpotlight on the Fear of Cancer Recurrence Inventory (FCRI)
Smith, A. B., Costa, D., Galica, J., Lebel, S., Tauber, N., van Helmondt, S. J., & Zachariae, R. (2020) · Psychology Research and Behavior Management · doi:10.2147/prbm.s231577 · Cited by 98
Self-citationRe‐validation and screening capacity of the 6‐item version of the Cancer Worry Scale
Custers, J. A. E., Kwakkenbos, L., van de Wal, M., Prins, J. B., & Thewes, B. (2018) · Psycho-Oncology · doi:10.1002/pon.4782 · Cited by 88
Self-citationRussell, L., Ugalde, A., Orellana, L., Milne, D., Krishnasamy, M., Chambers, R., Austin, D. W., & Livingston, P. M. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-018-4574-6 · Cited by 61
ConquerFear Authorship group, Sharpe, L., Turner, J., Fardell, J. E., Thewes, B., Smith, A. B., Gilchrist, J., Beith, J., Girgis, A., Tesson, S., et al. (2019) · Journal of Cancer Survivorship · doi:10.1007/s11764-019-00788-4 · Cited by 46
Self-citation
Metadata
- Authors
- Fardell, J. E., Jones, G., Smith, A. B., Lebel, S., Thewes, B., Costa, D., Tiller, K., Simard, S., Feldstain, A., Beattie, S., McCallum, M., on behalf of the Conquer Fear authorship group, & Butow, P.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2017-08-18
- Volume
- 27
- Issue
- 2
- Pages
- 492-499
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W2742135261
- Cited by
- 130
- References
- 15
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- beyondblue
- National Breast Cancer Foundation
- Cancer Australia (CAPdCCRS 1022584)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.